Clinical Trial Update: The Long-term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years [Phase 3]

View source ↗

Summary

Long-term Phase 3 trial evaluating the safety of eplerenone for hypertension in children aged 6 to 16 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• eplerenone (eplerenone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypertension | Phase 3 | Status: COMPLETED